From: Jay Fraser []
Sent: Tuesday, November 04, 2003 12:25 PM
To: Butler, Jennie C
Cc: Lawrence Weber
Subject: Docket Number 2003N-0361 - RESUBMISSION

Importance: High
Jennie Butler
Director, Division of Dockets Management
Food and Drug Administration

Re:  Docket No. 2003N-0361

Dear Ms. Butler:

I want to thank you for alerting us to the public nature of the docket submission.

I am attaching to this email/letter a revised submission to the docket. 

Please note that items that are specifically excluded due to their confidential nature are:

Tracer’s letter to Poppy Kendall dated September 5, 2003, along with any and all attachments and samples conveyed at that time.

The following documents that were attached to our submission to the Docket No. 2003N-0361:

WhitePaper(fiber).doc (note that this document was also attached to our letter to Mr. John Taylor on August 11, 2003 and is not authorized for public release)


Documents transmitted to the FDA prior to the submission to the docket that are authorized for submission to the docket are:

Tracer’s letter to Mr. John Taylor on August 11, 2003 (FDA-pharma-hhs.doc)

A PowerPoint file that was attached to the August 11th letter (FDA-pharma-hhs)

Additionally per our discussion this morning, I am re-submitting the following additional documents to the Docket No. 2003N-0361:


Jay Fraser
President & CEO
Tracer Detection Technology Corp.